Status:
WITHDRAWN
Long-term Consumption of Resistant Starch Type-4 (RS4)
Lead Sponsor:
Kansas State University
Collaborating Sponsors:
MGP Ingredients, Inc.
Conditions:
Cholesterol, Elevated
Overweight or Obesity
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The primary objective of the current proposal is to determine the effectiveness of long-term consumption of Fibersym® RW for improving blood lipids (including cholesterol) and body composition. The ov...
Detailed Description
This study will investigate the metabolic effects of daily RS4 consumption in overweight and obese adults. The investigators will recruit approximately 50 (BMI: 23-34.9kg/m2) adults ages 18-65yrs, who...
Eligibility Criteria
Inclusion
- BMI ≥ 23 kg/m2
- elevated to borderline-high LDL-cholesterol (116-159 mg/dL)
Exclusion
- known allergy to wheat or gluten
- currently taking medication for chronic disease including anti-inflammatory, anti-hypertensive, lipid lowering, glucose controlling, or steroidal medications
- taking any supplements that may affect metabolism
- having anemia or a history of anemia
- current smoker or a user in the past three months
- currently pregnant or lactating/planning to become pregnant during the intervention
- having elevated blood pressure (≥130mmHg/≥80mmHg)
- presence of diagnosed diabetes mellitus, inflammatory disease, atherosclerotic disease, or other relevant chronic conditions that may affect metabolic processes
- total cholesterol ≥ 240mg/dL.
Key Trial Info
Start Date :
February 18 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04277741
Start Date
February 18 2020
End Date
June 30 2023
Last Update
October 4 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Physical Activity and Nutrition Clinical Research Consortium
Manhattan, Kansas, United States, 66502